Scientific Presentations

Non-Viral DNA Delivery Coupled To TALEN Gene Editing Efficiently Correct The Sickle Cell Mutation In Long-Term HSCS - ESGCT 2023 - Poster Presentation

Download the PDF file

TALEN®-Edited Inducible Dual Car T-Cells Aimed at Safe and Effective Targeting Of Solid Tumors - CICON 2023 - Poster Presentation

Download the PDF file

Updated Results of the Phase I BALLI-01 Trial of UCART22, an Anti-CD22 Allogeneic CAR T-cell Product, in Patients with Relapsed or Refractory (R/R) CD22+ B-Cell Acute Lymphoblastic Leukemia (B-ALL) - EHA 2023 - Poster Presentation

Download the PDF file

UCART20x22: allogeneic dual CAR T-cells for the treatment of B-cell malignancies - ISCT 2023 - Oral Presentation

Download the PDF file

Comprehensive Analysis of the Editing Window of TALE Base Editors ISCT 2023 - Poster Presentation

Download the PDF file

Non-viral DNA delivery associated to TALEN® gene editing leads to highly efficient correction of sickle cell mutation in long-term repopulating hematopoietic stem cells  - ISCT 2023 - Poster Presentation

Download the PDF file

Expanding the Scope of Multiplex Engineering for Superior Generation of Efficient CAR T-cells - ASGCT 2023 - Poster Presentation

Download the PDF file

AMELI 01: A Phase I Trial of UCART123v1.2, an Anti CD123 Allogeneic CAR T Cell Product, in Adult Patients with Relapsed or Refractory (R/R) CD123+ Acute Myeloid Leukemia - ASGCT 2023 - Oral Presentation

Download the PDF file

Deciphering the benefits of variable delivery routes and molecular armoring to enhance efficacy of MUC1-CAR T-cells in targeting triple-negative breast cancer - AACR 2023 - Poster presentation

Download the PDF file

Cellectis Live Webcast Presentation- December 13, 2022

Download the PDF file